Article
Host-directed therapy with 2-Deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2
2022-05-24
Abstract excerpt
<h4>ABSTRACT</h4> Rhinoviruses (RVs) and coronaviruses (CoVs) upregulate host cell metabolic pathways such as glycolysis to meet their bioenergetic demands for rapid multiplication. Using the glycolysis inhibitor 2-deoxy-D-glucose (2-DG), we assessed the dose-dependent inhibition of viral replication of minor- and major-receptor group RVs in epithelial cells. 2-DG disrupted RV infection cycle by inhibiting templa...
Topics
Open a Topic to create a Post that cites this publication.
- Asthma and respiratory diseases
- Cytomegalovirus and herpesvirus research
- Herpesvirus Infections and Treatments
- Liver Disease Diagnosis and Treatment
- Respiratory viral infections research
- Viral-associated cancers and disorders
- Viral gastroenteritis research and epidemiology
- Virus-based gene therapy research
Identifiers and source
- Literature Corpus work
- 13b52d13-ec12-55e6-8e9a-036afd6aa86c
- DOI
- 10.1101/2022.05.24.493068
